-
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Average Recommendation of "Moderate Buy" by Brokerages
Source: Buzz FX / 22 Jan 2025 02:36:17 America/New_York
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Average Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat January 22, 2025 Share Link copied to clipboard. Celldex Therapeutics, Inc. ( NASDAQ:CLDX - Get Free Report ) has re
Read more...